Tech Stumbles as Healthcare Rallies; AI Demand Questions Loom

U.S. equity markets closed mixed overnight, with broad weakness in cyclical sectors offset by a sharp rally in healthcare and pockets of strength in select technology names. The S&P 500 fell 0.70% to $754.24, the Dow Jones declined 1.13%, and the Russell 2000 slipped 1.37%, though the Nasdaq 100 held relatively steady at -0.26%. The divergence signals sector rotation rather than broad-based selling—but questions about artificial intelligence demand growth are emerging.

The Healthcare Surge

ABVX exploded 24.3% and NVTS gained 19.3%, leading a healthcare sector rally that bucked the broader downturn. MMED (+15.9%), TGTX (+9.5%), and BRKR (+9.4%) also posted double-digit gains. Earnings beats fueled the move: GOTU posted a staggering 2,426% EPS beat, while AREC crushed expectations with a 1,056% EPS beat. Even M delivered a 550% beat. These aren't typical earnings surprises—they suggest potential lapping of weak prior-year comparisons or significant operational improvements. Healthcare's +0.76% sector performance masks the concentrated strength; the rest of the market couldn't keep pace.

The AI Question

Technology's 2.54% sector decline reflects growing caution about artificial intelligence investment returns. AVGO shares fell 12% premarket after missing revenue guidance, signaling that "AI demand momentum may be softer than" previously forecast. The semiconductor and cloud infrastructure complex—engines of the 2024–2025 rally—are facing reset expectations. This matters: broad tech weakness alongside healthcare strength suggests investors are repositioning from high-valuation growth toward more defensive or earnings-proven plays.

Earnings Beat Volume, But Guidance Matters

While earnings beats appear abundant—GME (+88% EPS beat), VSCO (+107%), M (+550%)—the revenue picture is murkier. GOTU managed a revenue miss of -84%; AREC missed -110%. This divergence is critical: companies beating EPS on cost-cutting alone, without revenue acceleration, shouldn't command the same enthusiasm as organic growth. The market's appetite for earnings-only beats is finite, particularly if those beats signal margin compression rather than business strength.

Bright Spots in the Gloom

Despite sector headwinds, several stocks flashed bullish technical signals. ZM (Zoom) registered as "Very Attractive" with three converging bullish signals, while DKS (DICK'S Sporting Goods), A (Agilent), RY (Royal Bank of Canada), and TMP (Tompkins Financial) all registered "Attractive" with multiple signal convergence. These names deserve closer scrutiny for mean-reversion or fundamental improvement plays.

Fresh analyst action provided mixed signals. AU (gold) received an upgrade to Outperform from RBC Capital, supporting haven demand. PVH dropped to Hold from Outperform at $98, and MUR faced a downgrade to Underperform from Jefferies. Neutral initiations at KRT (Goldman) and XPRO (KeyBanc) suggest limited conviction among major banks—a red flag in choppy markets.

What to Watch Today

Monitor semiconductor and cloud earnings for further AI demand signals. Watch whether AVGO's guidance miss sparks broader selloff in chip names or stabilizes as a one-time correction. Track healthcare volatility and whether today's momentum holds or fades. Analyst action on AU, PVH, and energy names may indicate institutional conviction shifts. Finally, keep eyes on the VIX and credit spreads; if real weakness emerges, defensive positioning will accelerate.